POINT BIOPHARMA GLOBAL INC. Lessee, Operating Lease, Liability, to be Paid
POINT BIOPHARMA GLOBAL INC. had Lessee, Operating Lease, Liability, to be Paid of $7.97 million as of 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue · last filed 2023-11-13
- 2023-09-30: Lessee, Operating Lease, Liability, to be Paid $7.97M.
- 2023-06-30: Lessee, Operating Lease, Liability, to be Paid $445.48K.
| Period end | Lessee, Operating Lease, Liability, to be Paid |
|---|---|
| 2023-09-30 | $7.97M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $445.48K 10-Q · filed 2023-08-14 |